Home » Topics » BioWorld Science

BioWorld Science
RSS

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

NextCure's NC-762 enters phase I/II trial in advanced or metastatic solid tumors

July 7, 2021

Studies report on developmental, adult neurogenesis

July 7, 2021

APOBEC3B may be a therapeutic target for treating ovarian cancer

July 7, 2021

Adamtsl3 knockout leads to dilated cardiomyopathy in aortic banded mice

July 7, 2021

Dapagliflozin similarly reduces risk of worsening in Black and White patients with HFrEF

July 7, 2021

SYNB-8802 significantly lowers urinary oxalate in NHP model of hyperoxaluria

July 7, 2021

NMPA accepts IND application for TST-002 anti-sclerostin monoclonal antibody

July 7, 2021

Intra-Cellular Therapies identifies new gamma-carboline derivatives

July 7, 2021

Ifenprodil will not advance into phase III trial for COVID-19

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...